Green Cross Medical Science Corporation (142280) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.108x

Based on the latest financial reports, Green Cross Medical Science Corporation (142280) has a cash flow conversion efficiency ratio of 0.108x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩5.01 Billion ≈ $3.40 Million USD) by net assets (₩46.37 Billion ≈ $31.42 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Green Cross Medical Science Corporation - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Green Cross Medical Science Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Green Cross Medical Science Corporation carry for a breakdown of total debt and financial obligations.

Green Cross Medical Science Corporation Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Green Cross Medical Science Corporation ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Schwager SN:SCHWAGER	0.113x
Mount Logan Capital Inc NEO:MLC	0.689x
Petra Diamonds Ltd LSE:PDL	-0.150x
Global Education Limited NSE:GLOBAL	0.078x
Maronan Metals Ltd AU:MMA	-0.281x
Kolon Industries Inc KO:120115	0.031x
Primotec Group Ltd TA:PRMG	0.068x
U-Media Communications TWO:6470	0.100x

Annual Cash Flow Conversion Efficiency for Green Cross Medical Science Corporation (2014–2025)

The table below shows the annual cash flow conversion efficiency of Green Cross Medical Science Corporation from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Green Cross Medical Science Corporation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩46.37 Billion ≈ $31.42 Million	₩7.20 Billion ≈ $4.88 Million	0.155x	+74.72%
2024-12-31	₩41.21 Billion ≈ $27.93 Million	₩3.66 Billion ≈ $2.48 Million	0.089x	-22.67%
2023-12-31	₩36.92 Billion ≈ $25.02 Million	₩4.24 Billion ≈ $2.87 Million	0.115x	-64.89%
2022-12-31	₩33.25 Billion ≈ $22.54 Million	₩10.88 Billion ≈ $7.37 Million	0.327x	+164.94%
2021-12-31	₩36.11 Billion ≈ $24.47 Million	₩-18.20 Billion ≈ $-12.33 Million	-0.504x	-224.76%
2020-12-31	₩56.47 Billion ≈ $38.27 Million	₩-8.76 Billion ≈ $-5.94 Million	-0.155x	-87.24%
2019-12-31	₩49.58 Billion ≈ $33.60 Million	₩-4.11 Billion ≈ $-2.78 Million	-0.083x	-146.02%
2018-12-31	₩15.34 Billion ≈ $10.40 Million	₩-516.61 Million ≈ $-350.10K	-0.034x	-125.18%
2017-12-31	₩23.23 Billion ≈ $15.75 Million	₩3.11 Billion ≈ $2.11 Million	0.134x	-64.95%
2016-12-31	₩26.85 Billion ≈ $18.20 Million	₩10.25 Billion ≈ $6.94 Million	0.382x	+302.32%
2015-12-31	₩28.87 Billion ≈ $19.56 Million	₩-5.45 Billion ≈ $-3.69 Million	-0.189x	-167.97%
2014-12-31	₩31.50 Billion ≈ $21.35 Million	₩-2.22 Billion ≈ $-1.50 Million	-0.070x	--

About Green Cross Medical Science Corporation

KQ:142280 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$56.95 Million

₩84.03 Billion KRW

Market Cap Rank

#21387 Global

#1366 in Korea

Share Price

₩3865.00

Change (1 day)

-1.65%

52-Week Range

₩3255.00 - ₩4705.00

All Time High

₩19450.00